Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Amgen Still Has Many Ways to Win
TheStreet.com
Wed, 07/27/16 - 10:00 am
Tags:
Amgen, earnings
Amgen (AMGN) Stock Down Ahead of Q2 Earnings Report
TheStreet.com
Tue, 07/26/16 - 11:02 am
Tags:
Amgen, earnings
Amgen, Inc. 2Q Earnings: Here’s What To Expect
Bidness, ETC
Sat, 07/23/16 - 10:50 am
Tags:
Amgen, earnings
Amgen and Allergan Study Finds Biosimilar Comparable to Herceptin
WSJ Online
Fri, 07/22/16 - 09:49 am
Tags:
Amgen, Allergan, biosimilars, Herceptin, ABP 980, Roche, breast cancer
U.S. FDA knocks back Novartis copy of Amgen's drug Neulasta
Yahoo/Reuters
Tue, 07/19/16 - 10:18 am
Tags:
FDA, Novartis, biosimilars, Amgen, Neulasta
Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan
Yahoo
Thu, 07/14/16 - 10:11 am
Tags:
Amgen, Daiichi Sankyo, Japan, biosimilars
Sandoz Enbrel biosim cruises at FDA panel, endangering key Amgen sales
Fierce Pharma
Wed, 07/13/16 - 06:22 pm
Tags:
Sandoz, Novartis, FDA, advisory panels, biosimilars, Enbrel, Amgen
Amgen touts new dosing option for underperforming cholesterol drug
BioPharma Dive
Wed, 07/13/16 - 04:04 pm
Tags:
Amgen, Repatha, PCSK9 inhibitors
FDA Panel Resoundingly Backs Amgen's Biosimilar Humira
Investors.com
Tue, 07/12/16 - 07:03 pm
Tags:
FDA, advisory panels, Amgen, biosimilars, Humira, ABP 501
FDA panel to review Humira, Enbrel biosimilars this week
BioPharma Dive
Tue, 07/12/16 - 09:22 am
Tags:
FDA, advisory panels, Humira, Enbrel, biosimilars, ABP-501, Amgen, AbbVie, GP2015, Novartis
FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor
Yahoo
Mon, 07/11/16 - 10:53 am
Tags:
FDA, Amgen, Repatha, Repatha Pushtronex, PCSK9 inhibitors
Amgen drug appears 'highly similar' to Humira -FDA staff
Yahoo/Reuters
Fri, 07/8/16 - 10:23 am
Tags:
Amgen, Humira, FDA, Enbrel, rheumatoid arthritis, ABP 501, biosimilars
Pfizer, Amgen, Regeneron Pharmaceuticals: How the PCSK9 Market is Evolving
Bidness, ETC
Thu, 07/7/16 - 03:41 pm
Tags:
Pfizer, Amgen, Regeneron, PCSK9 inhibitors, Repatha, Praluent
Why Pfizer Inc, Amgen, Inc. are Just as Fitting for Medivation Inc as Sanofi
Bidness, ETC
Tue, 07/5/16 - 10:00 am
Tags:
Pfizer, Amgen, Medivation, Sanofi, M&A
Biotech: What's Ahead For The Second Half Of 2016
Seeking Alpha
Tue, 07/5/16 - 09:57 am
Tags:
biotech, AbbVie, Amgen, Allergan, Anacor, Gilead Sciences, Medivation, Pfizer, Sanofi
Pfizer's bococizumab may hit the PCSK9 market just in time
Fierce Pharma
Thu, 06/30/16 - 09:32 am
Tags:
Pfizer, bococizumab, PCSK9 inhibitors, Amgen, Sanofi, Regeneron
Amgen, Inc. Fits Into Pfizer’s Restructuring Plans Perfectly
Bidness, ETC
Fri, 06/24/16 - 04:09 pm
Tags:
Amgen, Pfizer, restructuring, M&A
Amgen, Novartis Court Case May Ease US Launch of Biosimilars
Bidness, ETC
Thu, 06/23/16 - 09:56 am
Tags:
Amgen, Novartis, biosimilars, Zarxio, Supreme Court
2 Biotech Stocks That Could Raise Their Dividends -- and 1 That Won't
Motley Fool
Sat, 06/18/16 - 02:24 pm
Tags:
biotech, Amgen, Gilead Sciences, PDL Biopharma
Amgen, Inc. can Force Praluent Off Market but Regeneron Pharmaceuticals Inc May Still Be OK
Bidness, ETC
Thu, 06/16/16 - 03:22 pm
Tags:
Amgen, Sanofi, Regeneron, Praluent, Repatha, patents, PCSK9 inhibitors

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.